Gaucher

Gauch·er

(gō-shā'),

Philippe C.E., French physician, 1854-1918. See: Gaucher cells, Gaucher disease, pseudo-Gaucher cell.

Farlex Partner Medical Dictionary © Farlex 2012

References in periodicals archive ?

We expect to exit this year with three gene therapy programs in clinical trials - for Fabry, Gaucher and cystinosis," commented CEO Geoff MacKay.

Avrobio reports Q1 EPS (72c), consensus (72c)

M2 PHARMA-November 28, 2018-Orphazyme announces publication of manuscript on preclinical Proof-of-Concept of arimoclomol in Gaucher disease in EBioMedicine journal

Orphazyme announces publication of manuscript on preclinical Proof-of-Concept of arimoclomol in Gaucher disease in EBioMedicine journal

M2 EQUITYBITES-November 28, 2018-Orphazyme announces publication of manuscript on preclinical Proof-of-Concept of arimoclomol in Gaucher disease in EBioMedicine journal

Orphazyme announces publication of manuscript on preclinical Proof-of-Concept of arimoclomol in Gaucher disease in EBioMedicine journal

Global Banking News-November 28, 2018-Orphazyme announces publication of manuscript on preclinical Proof-of-Concept of arimoclomol in Gaucher disease in EBioMedicine journal

Orphazyme announces publication of manuscript on preclinical Proof-of-Concept of arimoclomol in Gaucher disease in EBioMedicine journal

NORDIC BUSINESS REPORT-June 22, 2018-Orphazyme enrols first patient in phase II clinical trial for Gaucher disease

Orphazyme enrols first patient in phase II clinical trial for Gaucher disease

Perinatal lethal Gaucher disease (PLGD) is a rarer variant of type 2 Gaucher disease (GD).

Perinatal Lethal Gaucher Disease due to RecNcil Recombinant Mutation in the GBA Gene Presenting with Hydrops Fetalis and Severe Congenital Anemia

There are around 7000 rare diseases but patients suffering from a particular segment of rare diseases called Lysosomal Storage Disorders (LSDs) like MPS (type I, II, III, IV & VI), Gaucher, Pompe, Fabry, etc.

Providing timely treatment to rare disease patients is need of the hour

Introduction: The Gaucher disease is a metabolic disorder due to deficiency or absence of acid [beta]-glucosidase enzyme.

Validity of the Enzymatic Activity Test of Glucocerebrosidase for the Diagnosis of Gaucher Disease, a Systematic Review/Validez de la prueba de actividad enzimatica de la glucocerebrosidasa para el diagnostico de enfermedad de Gaucher, revision sistematica/Validade do teste de atividade enzimatica da glucocerebrosidase para o diagnostico da doenca de Gaucher, revisao sistematica

Although Gaucher disease generally presents with massive splenomegaly, which one of the predisposing causes of a wandering spleen, literature shows only one report of a wandering spleen in a child with Gaucher disease.

Torsion of a wandering spleen in an adolescent with Gaucher disease

(Bone impairment in patients with Gaucher disease diagnosis).

TR-002: Afectacion osea en los pacientes con diagnostico de enfermedad de Gaucher

Mesenteric lymphadenopathy is a rare manifestation of Gaucher disease (GD) with only 26 cases reported worldwide and its outcome remains largely unknown.